
Planning, Writing and Reviewing Medical Device Clinical and Performance Evaluation Reports (CERs/PERs)
A Practical Guide for the European Union and Other Countries
- 1st Edition - September 19, 2024
- Imprint: Academic Press
- Author: Joy Frestedt
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 2 0 6 3 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 2 0 6 4 - 7
A Practical Guide to Planning, Writing, and Reviewing Medical Device Clinical Evaluation Reports guides readers through clinical data evaluation of medical devices that is in com… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteA Practical Guide to Planning, Writing, and Reviewing Medical Device Clinical Evaluation Reports guides readers through clinical data evaluation of medical devices that is in compliance with the EU MDR requirements and other similar regulatory requirements throughout the world. This book brings together knowledge learned as the author constructed hundreds of CERs and taught thousands of learners on how to conduct clinical data evaluations. This book will support training for clinical engineers, clinical evaluation scientists, and experts reviewing medical device CERs, and will help individual writers, teams and companies to develop stronger, more robust CERs.
- Identifies and explains data analysis for clinical evaluation of medical devices
- Teaches readers how to understand and evaluate medical device performance and safety in the context of new regulations
- Provides analysis of new clinical evaluation criteria in the context of medical device design as well as in-hospital deployment and servicing
Professionals in the clinical engineering and medical device evaluation sector, researchers in clinical engineering, biomedical engineering, and medical device design and development
- Cover image
- Title page
- Table of Contents
- Copyright
- List of figures
- List of tables
- List of boxes
- Preface
- 1 Historical context
- 2 Intended audience
- 3 Purpose, objectives, and goals
- 4 Main references and starting points
- Please send feedback
- Acknowledgments
- Chapter 1. Introduction
- 1.1 The start of clinical or performance evaluations
- 1.2 European Union clinical and performance evaluation regulatory requirements
- 1.3 Relevant general safety and performance requirements
- 1.4 Defining a clinical evaluation report/performance evaluation report
- 1.5 Comparing clinical evaluation reports and performance evaluation reports
- 1.6 The clinical evaluation report/performance evaluation report value proposition
- 1.7 Clinical evaluation/performance evaluation guidance documents
- 1.8 Designation of Notified Bodies under medical device regulation and in vitro diagnostic regulation
- 1.9 Linking clinical or performance evaluation, postmarket surveillance, and risk management systems in the quality management system
- 1.10 Quality management system control of clinical or performance evaluation
- 1.11 Clinical data
- 1.12 How clinical data sources change over time
- 1.13 Clinical evaluation report/performance evaluation report TYPES
- 1.14 Writing clinical evaluation/performance evaluation documents
- 1.15 Conclusions
- 1.16 Review questions
- References
- Chapter 2. Planning clinical/performance evaluations
- 2.1 Product must be a medical device
- 2.2 Follow the regulatory requirements
- 2.3 Use international regulatory standards
- 2.4 Specify how to document the plan in the quality management system
- 2.5 Clinical evaluation/performance evaluation strategies and process controls
- 2.6 TEN stage gates
- 2.7 Stage Gate 1: Kick-off meeting defines clinical evaluation/performance evaluation scope
- 2.8 Stage Gate 2: Clinical evaluation plan/performance evaluation plan development and version control
- 2.9 Clinical evaluation/performance evaluation planning by clinical evaluation/performance evaluation type
- 2.10 Check, sign, and date clinical evaluation plan/performance evaluation plan before clinical evaluation/performance evaluation begins
- 2.11 Conclusions
- 2.12 Review questions
- References
- Chapter 3. Identifying clinical/performance data
- 3.1 Clinical data definition
- 3.2 Clinical data identification process
- 3.3 Using appropriate software to store identified clinical data
- 3.4 Clinical trial data identification
- 3.5 Clinical literature data identification
- 3.6 Clinical experience data identification
- 3.7 Clinical data identification by clinical evaluation/performance evaluation type
- 3.8 Conclusions
- 3.9 Review questions
- References
- Chapter 4. Appraising clinical/performance data
- 4.1 Good appraisal processes are iterative
- 4.3 Clinical trial data appraisal
- 4.4 Clinical literature data appraisal
- 4.5 Clinical experience data
- 4.6 Clinical data appraisal by clinical eevaluation/perfomance evaluation type
- 4.7 Who should appraise clinical data?
- 4.8 What if the prior appraisal missed or duplicated clinical data?
- 4.9 Conclusions
- 4.10 Review questions
- References
- Chapter 5. Analyzing clinical/performance data
- 5.1 Quality management system must define clinical/performance data analysis process
- 5.2 In vitro diagnostic and other devices have different data analysis needs
- 5.3 Clinical/performance trial analysis
- 5.4 Clinical/performance literature analysis
- 5.5 Clinical experience analysis
- 5.6 Identifying benefit-risk ratio and PMCF needs
- 5.7 Clinical data analysis by Clinical Evaluation/Perfromance Evaluation type
- 5.8 Evaluator expertise is required
- 5.9 Conclusions
- 5.10 Review questions
- References
- Chapter 6. Establishing clinical benefit-risk ratios
- 6.1 Benefit-risk ratio requirements
- 6.2 Benefit-risk ratio evaluation methods
- 6.3 Benefit-risk ratio documentation
- 6.4 Define the benefit-risk ratio process steps
- 6.5 Conclusions
- 6.6 Review questions
- References
- Chapter 7. Writing clinical/performance evaluation documents
- 7.1 Stay organized and focused on clinical data
- 7.2 Understand why clinical evaluation/performance evaluation documents are difficult to write
- 7.3 Specify roles and responsibilities
- 7.4 Plan enough time to write the required documents
- 7.5 Follow the natural flow when writing
- 7.6 Evaluate statistical quality
- 7.7 Writing tips
- 7.8 Manager tips
- 7.9 Conclusions
- 7.10 Review questions
- References
- Chapter 8. Writing safety and performance summary documents
- 8.1 Writing objectives for summary documents
- 8.2 The quality management system must define the summary document writing process
- 8.3 Guidance for summary document writing
- 8.4 Summary document anatomy
- 8.5 Strategies for writing safety and performance summaries
- 8.6 Summary of safety and clinical performance/summary of safety and performance translations
- 8.7 Summary of safety and clinical performance/summary of safety and performance updates
- 8.8 Conclusions
- 8.9 Review questions
- References
- Chapter 9. Reviewing clinical/performance evaluation documents
- 9.1 Define document review process steps
- 9.2 Assign appropriate document reviewers and approvers
- 9.3 Assign reviewer roles and responsibilities
- 9.4 Deficiency letter examples
- 9.5 Examples of expert panel opinions and guidance
- 9.6 Conclusions
- 9.7 Review questions
- References
- Chapter 10. Integrating clinical evaluation, postmarket surveillance and risk management systems
- 10.1 Postmarket follow up is required
- 10.2 Postmarket follow up activities are varied
- 10.3 Integrate risk management, clinical evaluation and postmarket surveillance processes
- 10.4 Different departments need specific literature searches
- 10.5 “Signal detection” is required
- 10.6 Postmarket follow up guidance documents are available
- 10.7 Sufficient postmarket follow up clinical evidence
- 10.8 Integrating clinical/performance evaluation, postmarket surveillance and postmarket clinical follow up systems
- 10.9 Postmarket surveillance and periodic safety update report differences
- 10.10 Postmarket surveillance systems must be proactive and integrated
- 10.11 Conclusions
- 10.12 Review questions
- References
- Chapter 11. Understanding clinical evaluation regulations outside of Europe
- 11.1 Rest of world clinical evaluations
- 11.2 Australia
- 11.3 China
- 11.4 Association of Southeast Asian Nations
- 11.5 Examples of countries without specific clinical evaluation report/performance evaluation report requirements
- 11.6 Conclusions
- 11.7 Review questions
- References
- Chapter 12. Forecasting clinical evaluation future directions
- 12.1 Introduction
- 12.2 Better, more integrated clinical evaluation systems
- 12.3 Unifying clinical evaluation regulations for medical devices and in vitro diagnostic devices
- 12.4 Driving international relations and global change
- 12.5 Conclusions
- 12.6 Review questions without answers
- References
- Appendix A. Example regulatory evolution timeline
- Further reading
- Appendix B. MEDDEV guidance list
- Appendix C. Medical Device Coordinating Group endorsed guidance documents
- Appendix D. Appraisal question examples
- Appendix E. Notified Body clinical evaluation checklist
- E.1 General details
- E.2 Device description and intended application
- E.3 Intended therapeutic and/or diagnostic indications and claims
- E.4 Context of evaluation and choice of clinical data types
- E.5 Summary of clinical data and appraisal
- E.6 Data analysis
- E.7 Conclusions
- Appendix F. Clinical evaluation plan/performance evaluation plan requirements checklist
- Appendix G. Clinical evaluation standard operating procedure example 1 (short)
- G.1 Policy
- G.2 Purpose
- G.3 Responsibility
- G.4 Procedures
- G.5 References
- G.6 Appendices
- Appendix H. Clinical evaluation standard operating procedure example 2 (long)
- 1 Purpose and background
- 2 Scope
- 3 References and associated documents
- 4 Responsibilities
- 5 Procedure
- Appendix I. Clinical evaluation work instruction example
- Appendix J. Kick off meeting agenda/minutes/slides
- Appendix K. Clinical Evaluation Plan Template
- Table of Contents
- 1 Objective and Scope
- 2 Specifications and Acceptance Criteria
- 3 Device Description
- 4 Background and State of the Art (SOTA)
- 5 Clinical Evaluation Process
- 6 Postmarket Clinical Follow-up Planning
- 7 Clinical evolution report Conclusions
- 8 References
- Appendix L. Clinical evaluation report template
- Table of Contents
- Table of Abbreviations and Definitions of Terms
- 1 Executive summary
- 2 Purpose, specifications, and acceptance criteria (safety and performance criteria)
- 3 Device description
- 4 Clinical investigation review
- 5 Clinical literature review
- 6 Clinical experience review
- 7 Benefit/risk discussion (GSPR 1, 6, and 8 alignment)
- 8 Conclusions
- 9 References
- 10 Appendices
- Appendix M. Clinical data requirements checklists
- Appendix N. Declaration of Interest template
- Declaration of Interest form
- Appendix O. Summary of safety and clinical performance/summary of safety and performance template
- Appendix P. Benefit-risk ratio checklist
- Appendix Q. Clinical evaluation/performance evaluation strategy checklist
- Appendix R. Clinical data requirements matrix
- Appendix S. Reference list of regulatory jurisdictions
- Appendix T. Answers to review questions
- Index
- Edition: 1
- Published: September 19, 2024
- Imprint: Academic Press
- No. of pages: 576
- Language: English
- Paperback ISBN: 9780443220630
- eBook ISBN: 9780443220647
JF
Joy Frestedt
Joy Frestedt Is the President and CEO for Frestedt Incorporated, a consulting group of over 70 experts providing services in broad CRQE areas of clinical trial development and execution, as well as US and international regulatory compliance, management of corporate quality systems, and biomedical engineering. She has managed clinical research, regulatory affairs, and quality systems for more than 40 years and has published more than 100 manuscripts, as well as book chapters. With a PhD in Pathobiology from the University of Minnesota Medical School, her experience includes designing, conducting and overseeing clinical trials as well as negotiating regulatory submissions and developing quality systems for companies like the University of Minnesota, Orphan Medical, Astra Zeneca Pharmaceuticals, Johnson and Johnson, Medtronic, and Mayo Clinical Trial Services.
Affiliations and expertise
President and CEO, Frestedt Incorporated, St. Louis Park, MN, USARead Planning, Writing and Reviewing Medical Device Clinical and Performance Evaluation Reports (CERs/PERs) on ScienceDirect